Healthcare provider profile · identity verified

Peter A Pickhardt, MD

Family Practice · DEFOREST, WI · NPI 1821058959

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	398	104
Amlodipine Besylate	Amlodipine Besylate	197	57
Lisinopril	Lisinopril	180	50
Omeprazole	Omeprazole	175	47
Tamsulosin Hcl	Tamsulosin Hcl	164	42
Metoprolol Succinate	Metoprolol Succinate	136	34
Levothyroxine Sodium	Levothyroxine Sodium	120	29
Gabapentin	Gabapentin	118	26
Metformin Hcl Er	Metformin Hcl	113	30
Hydrochlorothiazide	Hydrochlorothiazide	110	26
Irbesartan	Irbesartan	109	30
Rosuvastatin Calcium	Rosuvastatin Calcium	109	29
Eliquis	Apixaban	98	22
Simvastatin	Simvastatin	97	26
Pantoprazole Sodium	Pantoprazole Sodium	84	20
Trazodone Hcl	Trazodone Hcl	84	23
Allopurinol	Allopurinol	76	20
Losartan Potassium	Losartan Potassium	76	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	12
Atenolol	Atenolol	64	16
Zolpidem Tartrate	Zolpidem Tartrate	62	suppressed
Carvedilol	Carvedilol	61	16
Oxycodone Hcl	Oxycodone Hcl	59	12
Metformin Hcl	Metformin Hcl	57	17
Tramadol Hcl	Tramadol Hcl	56	14
Escitalopram Oxalate	Escitalopram Oxalate	55	17
Furosemide	Furosemide	54	18
Tizanidine Hcl	Tizanidine Hcl	54	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	13
Famotidine	Famotidine	53	19
Farxiga	Dapagliflozin Propanediol	53	11
Duloxetine Hcl	Duloxetine Hcl	52	suppressed
Mounjaro	Tirzepatide	52	suppressed
Sertraline Hcl	Sertraline Hcl	51	15
Albuterol Sulfate Hfa	Albuterol Sulfate	50	25
Benazepril Hcl	Benazepril Hcl	50	17
Jardiance	Empagliflozin	50	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Xarelto	Rivaroxaban	46	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	40	18
Lorazepam	Lorazepam	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	11
Potassium Chloride	Potassium Chloride	38	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Finasteride	Finasteride	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Trulicity	Dulaglutide	32	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Oxycontin	Oxycodone Hcl	24	suppressed
Ozempic	Semaglutide	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	18
Glipizide	Glipizide	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Prednisone	Prednisone	22	18
Diazepam	Diazepam	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	13
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Naproxen	Naproxen	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Baclofen	Baclofen	17	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	11
Ziprasidone Hcl	Ziprasidone Hcl	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	11
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	14
Chlorthalidone	Chlorthalidone	14	suppressed
Ssd	Silver Sulfadiazine	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Xtampza Er	Oxycodone Myristate	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Valsartan	Valsartan	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Nystop	Nystatin	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error